Clots, Contrast Media and Catheterization

WebCAST

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

October 21, 2009

Expiration Date:

October 21, 2011

Intended Audience:

The educational activity is designed for all interventional cardiologists, cardiologists, and other health professionals who manage patients with acute coronary syndromes in the setting of the catheterization laboratory.

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

The following program has been supported
by an independent medical educational grant
from Guerbet, LLC.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Policy on Faculty Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Steven V. Manoukian, MD, FACC - Chairman
Director of Cardiovascular Research
Sarah Cannon Research Institute (SCRI)
Centennial Heart Cardiovascular Consultants
Medical Director Cardiovascular Services
Hospital Corporation of America (HCA)
Nashville, Tennessee

Consultant, Educational Grant, Research Support, and/or Employment: BMS, Guerbet LLC,
Sanofi-Aventis, The Medicines Company

Frederick Feit, MD, FACC
Associate Professor of Medicine
New York University School of Medicine
New York, NY

Consultant: The Medicines Company, CV Therapeutics
Stock Shareholder: Johnson & Johnson, The Medicines Company

Roxana Mehran, MD
Director Outcomes Research Data Coordination & Analysis
Columbia University Medical Center
Joint Chief Scientific Officer, Clinical Trial Center
Cardiovascular Research Foundation
New York, NY

Consultant: Cordis, BMS, The Medicines Company, Abbott, Bracco, Medtronic, Guebert
Grant/Research Support: The Medicines Company, BSC, Cordis, Regado, Therox, sanofiaventis,
Lilly Daichii Sankyo, Medtronic, Abbott, Guebert, Abiomed
Honorarium: The Medicines Company, BSC, Cordis, Regado, Therox, sanofi-aventis, Lilly
Daichii Sankyo, Medtronic, Abbott, Guebert, Abiomed

Program Managers and Disclosures

Gideon Bosker, MD
Nothing to Disclose

Milo Falcon
Nothing to Disclose

Denise Leary
Nothing to Disclose

Educational Objectives:

As a result of participating in this program, clinicians will be able to:

• Discuss about the role that cardiovascular contrast media (CM) can play in thrombosis mitigation and renal preservation in the setting of PCI
  
  
• List the physical, chemical, and biological properties—ionicity, molecular structure, and viscosity—of contrast agents used in PCI and their potential impact on renal function, thrombosis, and patient safety
  
  
• Apply landmark trials, registry data, and observational studies to optimize selection of CM in patients undergoing PCI
  
  
• Identify high-risk patients that may be appropriate candidates for specific CM shown to decrease risk of thrombotic events and/or renal dysfunction
  
  
• Explain how ionic properties, viscosity, and other chemical features may affect renal function and coagulation in the setting of PCI
  
  
• Optimize selection of contrast agents in the cardiac catheterization laboratory in order to reduce potential adverse events
  

Disclaimer:

Copyright © 2009 by CMEducation Resources, LLC and Pharmatecture, LLC All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved